Filter Publications By:

Binimetinib / Cancer


American Association for Cancer Research Annual Meeting

Preclinical Development of ARRY-162, A Potent and Selective MEK 1 / 2 Inhibitor

P. Lee, Ph.D., et al.

ARRY-502 / Asthma


American Academy of Allergy, Asthma & Immunology Annual Meeting

Potent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis

L. L. Carter, et al.